$BRFH
BARFRESH FOOD GROUP INC.

2024 Q2 Form 10-Q Financial Statement

#000149315224019816 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $1.464M $2.829M $1.922M
YoY Change -3.11% 35.29% 34.31%
Cost Of Revenue $955.0K $1.659M $1.280M
YoY Change -7.91% 34.22% 39.89%
Gross Profit $509.0K $1.170M $642.0K
YoY Change 7.38% 36.84% 24.42%
Gross Profit Margin 34.77% 41.36% 33.4%
Selling, General & Admin $1.454M $1.552M $1.226M
YoY Change 30.05% -6.56% -18.38%
% of Gross Profit 285.66% 132.65% 190.97%
Research & Development $17.00K $30.00K $27.00K
YoY Change -51.43% 42.86% -22.86%
% of Gross Profit 3.34% 2.56% 4.21%
Depreciation & Amortization $56.00K $74.00K $73.00K
YoY Change -35.63% -19.57% -40.16%
% of Gross Profit 11.0% 6.32% 11.37%
Operating Expenses $1.520M $1.619M $1.343M
YoY Change 25.0% -8.27% -18.61%
Operating Profit -$1.011M -$449.0K -$701.0K
YoY Change 36.25% -50.66% -38.18%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.011M -$449.0K -$701.0K
YoY Change 36.25% -50.66% -62.71%
Income Tax
% Of Pretax Income
Net Earnings -$1.011M -$449.0K -$701.0K
YoY Change 36.25% -50.66% -62.71%
Net Earnings / Revenue -69.06% -15.87% -36.47%
Basic Earnings Per Share -$0.07 -$0.03
Diluted Earnings Per Share -$0.07 -$0.03 -$0.05
COMMON SHARES
Basic Shares Outstanding 14.72M shares 14.51M shares 13.92M shares
Diluted Shares Outstanding 14.72M shares 14.50M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $383.0K $1.167M $1.891M
YoY Change -59.77% -25.48% -32.66%
Cash & Equivalents $383.0K $1.167M $1.891M
Short-Term Investments
Other Short-Term Assets $122.0K $230.0K $67.00K
YoY Change 23.23% -39.47% -76.9%
Inventory $1.534M $1.284M $1.214M
Prepaid Expenses
Receivables $671.0K $1.366M $821.0K
Other Receivables $19.00K $20.00K $160.0K
Total Short-Term Assets $2.729M $4.067M $4.153M
YoY Change 9.55% 13.51% -5.03%
LONG-TERM ASSETS
Property, Plant & Equipment $300.0K $350.0K $409.0K
YoY Change -52.15% 17.85% 5.14%
Goodwill
YoY Change
Intangibles $210.0K $226.0K $241.0K
YoY Change -23.64% -22.34% -21.24%
Long-Term Investments
YoY Change
Other Assets $92.00K $105.0K $7.000K
YoY Change 1214.29% 1400.0% 0.0%
Total Long-Term Assets $602.0K $681.0K $657.0K
YoY Change -33.77% 14.45% -8.75%
TOTAL ASSETS
Total Short-Term Assets $2.729M $4.067M $4.153M
Total Long-Term Assets $602.0K $681.0K $657.0K
Total Assets $3.331M $4.748M $4.810M
YoY Change -2.03% 13.64% -5.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $843.0K $1.328M $1.670M
YoY Change 8.77% 1.68% -17.86%
Accrued Expenses $155.0K $225.0K $85.00K
YoY Change -54.41% -11.76% -70.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.544M $2.086M $2.307M
YoY Change -20.29% -10.59% -10.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $111.0K $126.0K
YoY Change
Total Long-Term Liabilities $111.0K $126.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.544M $2.086M $2.307M
Total Long-Term Liabilities $111.0K $126.0K $0.00
Total Liabilities $1.655M $2.212M $2.307M
YoY Change -14.56% -5.19% -10.3%
SHAREHOLDERS EQUITY
Retained Earnings -$62.26M -$61.25M -$60.80M
YoY Change 4.42% 3.29% 4.13%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.676M $2.536M $2.503M
YoY Change
Total Liabilities & Shareholders Equity $3.331M $4.748M $4.810M
YoY Change -2.03% 13.64% -5.56%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$1.011M -$449.0K -$701.0K
YoY Change 36.25% -50.66% -62.71%
Depreciation, Depletion And Amortization $56.00K $74.00K $73.00K
YoY Change -35.63% -19.57% -40.16%
Cash From Operating Activities -$780.0K -$769.0K -$948.0K
YoY Change -5.45% -38.08% 3168.97%
INVESTING ACTIVITIES
Capital Expenditures $4.000K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.000K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $45.00K 1.830M
YoY Change
NET CHANGE
Cash From Operating Activities -780.0K -$769.0K -948.0K
Cash From Investing Activities -4.000K 0.000
Cash From Financing Activities 0.000 $45.00K 1.830M
Net Change In Cash -784.0K -$724.0K 882.0K
YoY Change -4.97% -41.71% -3141.38%
FREE CASH FLOW
Cash From Operating Activities -$780.0K -$769.0K -$948.0K
Capital Expenditures $4.000K $0.00
Free Cash Flow -$784.0K -$948.0K
YoY Change -4.97% 3168.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity File Number
EntityFileNumber
001-41228
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
BARFRESH FOOD GROUP INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1994406
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90010
CY2024Q1 dei City Area Code
CityAreaCode
310
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
598-7113
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001487197
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
usd
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
usd
CY2024Q1 BRFH Amounts Included In Measurement Of Lease Liabilities
AmountsIncludedInMeasurementOfLeaseLiabilities
usd
CY2023Q1 us-gaap Notes Issued1
NotesIssued1
usd
CY2023Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
CY2023Q1 BRFH Acquisition Of Longterm Software License In Exchange For Contract Payable
AcquisitionOfLongtermSoftwareLicenseInExchangeForContractPayable
usd
CY2024Q1 BRFH Value Of Shares Relinquished In Modification Of Stockbased Compensations Awards
ValueOfSharesRelinquishedInModificationOfStockbasedCompensationsAwards
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3600 Wilshire Blvd.
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1720
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
Not Applicable
CY2024Q1 dei Security12b Title
Security12bTitle
Common stock, $0.000001 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
BRFH
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14719875 shares
CY2024Q1 us-gaap Cash
Cash
1167000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1366000 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
20000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
1284000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
230000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
4067000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
350000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
226000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
105000 usd
CY2024Q1 us-gaap Assets
Assets
4748000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1328000 usd
CY2024Q1 us-gaap Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current
AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent
499000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
225000 usd
CY2024Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
34000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2086000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
126000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2212000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
23000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
23000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14719875 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14719875 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14420105 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14420105 shares
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63781000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61245000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2536000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4748000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2829000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
1659000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1236000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
1170000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
855000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
694000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
667000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
858000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
994000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
67000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
83000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
1619000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1744000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-449000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-889000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14500863 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14500863 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12977000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12977000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-449000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-889000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
366000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
268000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
74000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86000 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
8000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
545000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
445000 usd
CY2024Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-140000 usd
CY2023Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-90000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
70000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
107000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
92000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-271000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-228000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
93000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-769000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1224000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
65000 usd
CY2024Q1 BRFH Repurchases From Stock Compensation Program
RepurchasesFromStockCompensationProgram
20000 usd
CY2023Q1 BRFH Repurchases From Stock Compensation Program
RepurchasesFromStockCompensationProgram
18000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-724000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1242000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1891000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3019000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1167000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1777000 usd
CY2023Q1 BRFH Amounts Included In Measurement Of Lease Liabilities
AmountsIncludedInMeasurementOfLeaseLiabilities
20000 usd
CY2024Q1 us-gaap Notes Issued1
NotesIssued1
71000 usd
CY2024Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
136000 usd
CY2024Q1 BRFH Acquisition Of Longterm Software License In Exchange For Contract Payable
AcquisitionOfLongtermSoftwareLicenseInExchangeForContractPayable
154000 usd
CY2023Q1 BRFH Value Of Shares Relinquished In Modification Of Stockbased Compensations Awards
ValueOfSharesRelinquishedInModificationOfStockbasedCompensationsAwards
24000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zDTvHJkK3bg1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z53mXTHgArkk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vendor Concentrations</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is exposed to supply risk as a result of concentration in its vendor base resulting from the use of a limited number of contract manufacturers. Purchases from the Company’s significant contract manufacturers as a percentage of all finished goods purchased were as follows:</span></p> <p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zBgrMY0DbIh1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <span id="xdx_8BC_zE9Eyy9uzER1" style="display: none">Schedule of Contract Manufacturers Percentage of Finished Goods</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20240101__20240331_zTwC3uhURSU8" style="border-bottom: Black 1.5pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20230331_zqJuChtusXhh" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ManufacturerAMember_zzSXTRJMu3Vh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Manufacturer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">63</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">48</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_40C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ManufacturerBMember_zqSXMH6k1on9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Manufacturer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46</td><td style="text-align: left">%</td></tr> <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ManufacturerCMember_zR8s59ryHDL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Manufacturer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left">%</td></tr> <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_hus-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ManufacturerCMember_zbJRYBv6zJCb" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Concentration risk percentage</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A9_zJbem6ROzOp9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2024Q1 BRFH Shipping And Storage Costs
ShippingAndStorageCosts
364000 usd
CY2023Q1 BRFH Shipping And Storage Costs
ShippingAndStorageCosts
311000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21000 usd
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zKKkTbFDiBvg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reclassifications</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to the 2023 financial statements to conform to the 2024 presentation, namely stock-based compensation paid to the Company’s directors has been reclassified from stock and options issued for services and shares repurchased for employee tax withholding under the Company’s stock compensation program have been reclassified to financing activities in the consolidated statement of cash flows, with corresponding changes reflected in the statement of stockholders’ equity for the three months ended March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
83000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1744000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-889000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-889000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1224000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
28000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
28000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1256000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1186000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
1284000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1214000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2950000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2956000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2600000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2547000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
350000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
409000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
59000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
71000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
7000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
4000 usd
CY2024Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-03-31
CY2024Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
extended in a series of amendments through September 30, 2024.
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
20000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
20000 usd
CY2022 us-gaap Multiemployer Plan Increase In Employer Contribution Business Combination Percentage
MultiemployerPlanIncreaseInEmployerContributionBusinessCombinationPercentage
0.52 pure
CY2021 us-gaap Multiemployer Plan Increase In Employer Contribution Business Combination Percentage
MultiemployerPlanIncreaseInEmployerContributionBusinessCombinationPercentage
0.42 pure
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
2000000 usd
us-gaap Debt Instrument Description
DebtInstrumentDescription
The debt was available to be drawn in 25% increments, maturing on the anniversary of the draw, bearing interest at 10% per annum for the term, regardless of earlier payment or conversion, and was mandatorily convertible as to principal and interest into shares of the Company’s common stock at any time prior to maturity at the greater of $1.20 or 85% of the volume-weighted average price of the common stock for the ten trading days immediately preceding the written notice of the conversion (the “Conversion Price”).
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
1390000 usd
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1207000 usd
CY2023Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
820160 shares
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
470000 usd
CY2023Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
653000 usd
CY2023Q4 BRFH Debt Conversion Accrued Interest Amount
DebtConversionAccruedInterestAmount
4000 usd
CY2023Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
495331 shares
CY2024Q1 us-gaap Convertible Debt
ConvertibleDebt
136000 usd
CY2024Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
124208 shares
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
30000 usd
CY2024Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
71000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2933000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-18000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
268000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
24000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-889000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2278000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2503000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2503000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-20000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
366000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
136000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-449000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2536000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2536000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
122739 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
9.10
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
77000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
587091 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.50
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M6D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
43695 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.50
CY2024Q1 BRFH Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Issued
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2Issued
P8Y
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
630786 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.15
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
582316 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.31
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M6D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P8Y
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.844 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039 pure
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.15
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-769000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1167000 usd

Files In Submission

Name View Source Status
0001493152-24-019816-index-headers.html Edgar Link pending
0001493152-24-019816-index.html Edgar Link pending
0001493152-24-019816.txt Edgar Link pending
0001493152-24-019816-xbrl.zip Edgar Link pending
brfh-20240331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
brfh-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
form10-q_htm.xml Edgar Link completed
brfh-20240331_cal.xml Edgar Link unprocessable
brfh-20240331_def.xml Edgar Link unprocessable
brfh-20240331_lab.xml Edgar Link unprocessable